Clinical trial registries, biotechnology news outlets

ProfluentBio Launches OpenCRISPR-1, First AI-Designed Open-Source Gene Editor

Apr 23, 2024, 01:49 AM

ProfluentBio has announced the successful deployment of the first ever AI-designed gene editor, OpenCRISPR-1, marking a significant advancement in genetic engineering. This innovative tool, developed using ProfluentBio's large language models, consists of a Cas9-like protein and guide RNA. The company has decided to freely release the molecules under the OpenCRISPR initiative, aiming to democratize access to cutting-edge gene editing capabilities and accelerate the development of personalized medicine. The release of OpenCRISPR-1 is expected to revolutionize the field of biomedicine by enabling more widespread and ethical use of CRISPR technologies. Coverage of this development has been provided by @nytimes, with further details available in an article by @cademetz.